Form 4: Nuvalent Executive Darlene Noci Sells Shares Under 10b5-1 Trading Plan

Darlene Noci, Chief Development Officer of Nuvalent, Inc., executed sales of Class A Common Stock on September 3, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Darlene Noci, Chief Development Officer of Nuvalent, Inc., reported the sale of Nuvalent [NUVL] Class A Common Stock on September 3, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 21, 2023.
• A total of 5,000 shares were acquired through the exercise of stock options at a price of $18.93 per share.
• Noci sold 1,978 shares at a weighted average price of $83.95, 2,510 shares at $84.56, and 512 shares at $85.64.
• Following these transactions, Noci directly owns 33,300 shares of Class A Common Stock and 40,800 stock options.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transactions were pre-planned under a 10b5-1 trading plan. It doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

Insider transactions are routinely monitored by investors as they can provide signals, though sales under 10b5-1 plans are pre-scheduled and may not reflect current sentiment.

Stakeholder Impact

• The stock sales by a company executive may be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates